APHY 102 14.2

Overview and Origin of Formed Elements

  • Composition of Formed Elements:

    • Blood's formed elements comprise red blood cells (erythrocytes), white blood cells (leukocytes), and platelets (thrombocytes).
    • Platelets are classified as cell fragments rather than complete blood cells, though they remain vital functional components of the cardiovascular and hemostatic systems.

  • Hematopoiesis (Blood Cell Formation):

    • Definition: Hematopoiesis is the biological process responsible for the formation and development of all blood cells.
    • Site of Origin: Formed elements originate in the red bone marrow from hematopoietic stem cells, also known as hemocytoblasts.
    • Differentiation Dynamics:
    • Hematopoietic stem cells possess the capacity to divide symmetrically to replenish the stem cell pool, or divide and differentiate to yield specialized progenitor cell lines.
    • Stem cells give rise to two primary precursor lineages: myeloid stem cells and lymphoid stem cells.
    • Hematopoietic growth factors are secreted chemical signals that regulate gene expression by activating specific sets of genes and repressing others, sculpting the mature formed elements and immune cell lineages.
    • Ontogeny of Bone Marrow:
    • In infants, hematopoiesis occurs throughout the entirety of the skeleton, where all bone marrow spaces consist of active, blood-producing red marrow.
    • In adults, the majority of marrow cavities within fully developed bones transition into yellow marrow, dedicated primarily to adipocyte fat storage, restricting red bone marrow to specific skeletal regions.

Development of red blood cells, platelets, and white blood cells from hematopoietic stem cells in bone marrow

Red Blood Cells (Erythrocytes): Morphology, Function, and Gas Transport

  • Morphology and Physical Dimensions:
    • Erythrocytes are tiny, biconcave discs measuring approximately 7.5 μm7.5\,\mu\text{m} in diameter.
    • They exhibit a distinct geometry that is relatively thin near the center and thicker around the outer rim.
    • Cytoskeletal Architecture: Specialized intracellular proteins bridge the cell membrane to the underlying cytoskeleton, providing high mechanical flexibility. This enables erythrocytes to undergo reversible deformation to transit through tortuous microvascular capillaries without rupturing.
    • Functional Advantages of Biconcave Geometry:
    • Yields an increased surface-area-to-volume ratio, facilitating rapid diffusion of respiratory gases across the plasma membrane.
    • Minimizes the intracellular diffusion distance, placing the membrane in close physical proximity to cytoplasmic hemoglobin molecules.

Scanning electron micrograph of biconcave human red blood cells

  • Hemoglobin Content and Gas Transport:

    • Hemoglobin constitutes approximately one-third of the total cytoplasmic volume of an erythrocyte, giving whole blood its characteristic color.
    • The remainder of the erythrocyte consists predominantly of water, membrane components, electrolytes, and metabolic enzymes.
    • Normal Blood Hemoglobin Concentrations:
    • Adult males: 13–18 g/100 mL13\text{--}18\,\text{g}/100\,\text{mL}
    • Adult females: 12–16 g/100 mL12\text{--}16\,\text{g}/100\,\text{mL}
    • Oxyhemoglobin vs. Deoxyhemoglobin:
    • When hemoglobin complexes with molecular oxygen, it forms oxyhemoglobin, which appears bright red.
    • Upon release of oxygen to peripheral tissues, it becomes deoxyhemoglobin, which appears noticeably darker.

  • Pathophysiology of Cyanosis:

    • Prolonged systemic or localized oxygen deficiency (hypoxia) produces cyanosis, a condition where the skin and mucous membranes take on a bluish cast due to elevated concentrations of superficial deoxyhemoglobin.
    • The blood itself does not turn blue; rather, optical dispersion and light absorption/reflection characteristics of overlying skin tissues produce a blue hue.
    • Exposure to extreme cold can induce localized cyanosis by triggering superficial vasoconstriction, which slows blood flow through cutaneous capillary beds, driving greater peripheral oxygen extraction and an increased local concentration of deoxyhemoglobin.

  • Metabolic and Structural Specializations:

    • During erythroid maturation, precursor cells extrude their nuclei (nuclear extrusion), providing maximal internal space for hemoglobin accumulation.
    • Lacking a nucleus, mature circulating erythrocytes cannot replicate or synthesize structural proteins.
    • Lacking mitochondria, erythrocytes generate ATP solely through anaerobic glycolysis, preventing the consumption of the oxygen molecules they transport.
    • Lifespan and Senescence:
    • The average erythrocyte lifespan is approximately 120 days120\,\text{days}.
    • A typical red blood cell travels through the cardiovascular circuit roughly 75,00075,000 times before mechanical stress stiffens its membrane.
    • Senescent, damaged, or rigid erythrocytes are phagocytized and degraded by tissue macrophages within the spleen and liver.

Clinical Perspectives: Sickle Cell Disease and Malaria Resistance

  • Molecular Etiology of Sickle Cell Disease:
    • Caused by a single point mutation (DNA base substitution) altering a single amino acid residue within the globin protein chain of hemoglobin.
    • The mutated hemoglobin undergoes self-polymerization under deoxygenated conditions, causing intracellular crystalline filaments to form.
    • This aggregation deforms erythrocytes into rigid, sickle-shaped configurations that adhere to vascular endothelium.

Light micrograph of sickled erythrocytes in sickle cell disease

  • Clinical Manifestations and Complications:

    • Vaso-occlusive Crises: Fragile, sickled cells lodge within microvessels, occluding local blood flow. Microvascular ischemia causes localized hypoxia, accelerating further erythrocyte sickling in a positive feedback loop.
    • Pain Syndromes: Severe ischemic pain develops downstream of obstructions, predominantly affecting the bones, hands, and feet.
    • Hemolytic Anemia: Accelerated destruction of fragile sickle cells leads to severe systemic fatigue and reduced oxygen delivery.
    • Splenic Damage: Continuous vascular occlusion and overwork damage the spleen early in childhood, compromising innate immune filtering and increasing vulnerability to severe systemic bacterial infections.

  • Therapeutic Approaches:

    • Prophylactic Antibiotics: Daily antibiotic regimens are administered starting in early childhood to prevent opportunistic infections resulting from splenic functional loss.
    • Transfusion Therapy: Blood transfusions are deployed during acute vaso-occlusive crises to restore tissue perfusion and dilute sickled cells.
    • Hydroxyurea Pharmacotherapy: Hydroxyurea stimulates reactivation of fetal hemoglobin production, an isoform naturally produced only during fetal gestation that has higher oxygen affinity. Fetal hemoglobin prevents hemoglobin polymerization, maintaining cell flexibility until erythrocytes reach the lungs to be reoxygenated.
    • Hematopoietic Stem Cell Transplantation: Allogeneic bone marrow or donor umbilical cord stem cell transplants can cure the disorder, though they carry a risk of graft-versus-host complications and mortality.
    • Pyruvate Kinase Activation: Patients with sickle cell disease frequently exhibit variants in the PKLR gene, which encodes red blood cell pyruvate kinase (PKR), an enzyme central to glycolytic metabolism and red blood cell survival. Pharmaceutical activators of PKR are being tested to mitigate acute pain.
    • Gene Editing: Emerging technologies use ex vivo genome editing to correct the causative mutation in patient-derived hematopoietic stem and progenitor cells, which are re-infused following bone marrow conditioning.

  • Heterozygote Advantage (Incomplete Dominance):

    • Heterozygotes possessing one sickle cell allele and one normal hemoglobin allele display sickle cell trait.
    • These individuals obtain significant innate protection against severe malaria, a mosquito-transmitted disease caused by the protozoan Plasmodium falciparum, maintaining the sickle gene at high frequencies in malaria-endemic regions.

Erythrocyte Life Cycle, Production, and Homeostatic Regulation

  • Erythrocyte Production (Erythropoiesis):

    • Prenatal Sites: During embryonic and fetal development, erythropoiesis proceeds sequentially within the yolk sac, liver, and spleen.
    • Postnatal Sites: After birth, red blood cell synthesis is restricted almost entirely to red bone marrow.
    • Differentiation Pathway:Hematopoietic Stem Cell⟶Myeloid Stem Cell⟶Erythroblast⟶Reticulocyte⟶Mature Erythrocyte\text{Hematopoietic Stem Cell} \longrightarrow \text{Myeloid Stem Cell} \longrightarrow \text{Erythroblast} \longrightarrow \text{Reticulocyte} \longrightarrow \text{Mature Erythrocyte}
    • Erythroblasts: Undergo mitotic divisions and synthesize substantial quantities of hemoglobin.
    • Nuclear Extrusion: Erythroblast nuclei shrink and are extruded in a membrane-bound envelope, which is phagocytosed and degraded by bone marrow macrophages.
    • Reticulocytes: Immature, enucleated cells that retain residual endoplasmic reticulum and ribosomes (forming a stained meshwork or reticulum). Reticulocytes enter circulating blood and degrade their remaining organelles within 1–2 days1\text{--}2\,\text{days} to become fully mature erythrocytes.

  • Erythrocyte Counts (RBCC/RCC):

    • Quantified as the number of red blood cells per microliter (μL\mu\text{L}, mcL\text{mcL}, or 1 mm31\,\text{mm}^3) of whole blood:
    • Adult males: 4,700,000–6,100,000 cells/μL4,700,000\text{--}6,100,000\,\text{cells}/\mu\text{L}
    • Adult females: 4,200,000–5,400,000 cells/μL4,200,000\text{--}5,400,000\,\text{cells}/\mu\text{L}
    • Children: 4,500,000–5,100,000 cells/μL4,500,000\text{--}5,100,000\,\text{cells}/\mu\text{L}
    • Counts rise physiologically following prolonged strenuous exercise or acclimation to high altitudes where atmospheric pressure falls.

  • Negative Feedback Regulation via Erythropoietin (EPO):

    • Trigger: Tissue hypoxemia (lowered blood oxygen saturation).
    • Endocrine Response: Renal peritubular cells (and to a lesser degree the liver) detect reduced oxygenation and secrete the glycoprotein hormone erythropoietin (EPO) into circulation. (In the fetus, the liver is the primary source of EPO).
    • Action: EPO travels through the blood to the red bone marrow, binding progenitor receptors to accelerate erythroblast proliferation and reticulocyte release.
    • Homeostatic Resolution: The increased circulating red blood cell population raises oxygen-carrying capacity, relieving hypoxia and downregulating renal EPO secretion via negative feedback.
    • Pathological Consequences in Chronic Lung Disease: In conditions like emphysema, alveolar surface area for gas exchange is lost. The resulting arterial hypoxemia drives chronic EPO overproduction by the kidneys, inducing secondary polycythemia without improving gas exchange capacity.

  • Polycythemia:

    • An excessive, abnormal increase in circulating red blood cells.
    • Etiologies: High altitudes, tobacco smoking, dehydration, pulmonary diseases, erythropoietin-secreting tumors, or illegal exogenous EPO doping in athletics.
    • Pathology: Dramatically increases blood viscosity, raising peripheral resistance, slowing blood flow, promoting vascular thrombosis, and placing high stress on the heart.

Dietary Influences and Anemia Classifications

  • Essential Dietary Factors:

    • Vitamin B12: Essential for DNA synthesis and cellular replication across all tissues. Highly mitotic hematopoietic stem cells are vulnerable to its absence. Absorption requires gastric intrinsic factor, secreted by stomach parietal cells; absence of intrinsic factor impairs small intestinal uptake.
    • Folic Acid: A B-complex vitamin absorbed through the small intestine, required for purine/pyrimidine DNA synthesis during erythropoiesis.
    • Iron: Essential trace mineral incorporated into the central coordination complex of heme rings during hemoglobin synthesis. Conserved and recycled during erythrocyte turnover. Intestinal absorption is slow and modulated by internal stores (upregulated during depletion, downregulated during saturation).
    • Dietary Enhancers/Inhibitors: Ascorbic acid (vitamin C) enhances intestinal iron absorption. Tannic acid in tea binds dietary iron, preventing intestinal uptake.

  • Pathophysiological Types of Anemia:

    • Anemia is defined as a deficiency in total circulating erythrocyte numbers or a reduction in the hemoglobin concentration per erythrocyte, reducing blood oxygen-carrying capacity.
    • Iron-Deficiency Anemia: Results from dietary deficiency, chronic gastrointestinal bleeding ulcers, or heavy menstruation; marked by hypochromic microcytic cells with pronounced central pallor.
    • Pernicious Anemia: Autoimmune destruction of gastric parietal cells or gastric atrophy causing intrinsic factor deficiency, impairing vitamin B12 absorption; produces fragile, abnormally large, thin-membraned macrocytic erythrocytes.
    • Aplastic Anemia: Destruction of hematopoietic red bone marrow tissue induced by ionizing radiation, toxic chemicals, medications, viruses, or cancer.
    • Hemolytic Anemia: Premature rupture and destruction of erythrocytes, triggered by severe bacterial infections, toxic venom, or ABO/Rh blood transfusion incompatibilities.
    • Hemorrhagic Anemia: Acute or chronic reduction in erythrocyte count following major blood loss or severe hemorrhage.
    • Thalassemia: An inherited genetic hemoglobinopathy characterized by absent or deficient synthesis of globin chains, producing microcytic, short-lived erythrocytes.
    • Relative Anemia of Pregnancy: A physiological hemodilution where maternal plasma fluid retention expands total blood volume proportionally faster than red cell mass, lowering hematocrit.

Erythrocytes with central pallor in iron-deficiency anemia

Erythrocyte Destruction and Hemoglobin Degradation

  • Mechanical Senescence:

    • Aging erythrocytes lose membrane elasticity as their surface proteins deteriorate, making them vulnerable to mechanical shear stress when navigating capillaries, particularly within exercising skeletal muscle beds.
    • Fragile cells rupture while navigating the narrow, filtering sinusoid spaces of the spleen and liver.

  • Macrophage Phagocytosis and Breakdown Cascade:

    • Resident tissue macrophages in the spleen and liver engulf cellular fragments and break down hemoglobin:
    1. Globin Degradation: Hemoglobin dissociates into four polypeptide globin chains and four iron-containing heme groups. Globin chains are digested into free amino acids that enter the plasma amino acid pool or are metabolized by macrophages.
    2. Heme Cleavage: Heme groups are enzymatically broken down, releasing their central coordinate iron ion (Fe\text{Fe}) and converting the tetrapyrrole ring into biliverdin (C33H34O6N4\text{C}_{33}\text{H}_{34}\text{O}_6\text{N}_4), a green pigment.
    3. Iron Recycling and Storage:
      • Released iron binds the plasma transport beta-globulin transferrin and travels to the red bone marrow to synthesize new hemoglobin.
      • Excess iron is stored inside hepatocytes and macrophages bound to the intracellular protein storage complex ferritin (accounting for approximately 80%80\% of stored bodily iron).
    4. Bilirubin Conversion: Biliverdin is chemically reduced into bilirubin (C33H36O6N4\text{C}_{33}\text{H}_{36}\text{O}_6\text{N}_4), an orange-yellow pigment.
    5. Bile Secretion: Biliverdin and bilirubin are taken up by the liver and excreted into bile as bile pigments, discharging into the duodenum for elimination via the feces.

Chemical decomposition of heme into iron, biliverdin, and bilirubin

White Blood Cells (Leukocytes): Classes, Properties, and Immune Functions

  • General Characteristics and Differentiation:

    • Leukocytes defend the host against pathogenic microorganisms and foreign macromolecular invaders.
    • Differentiate from hematopoietic stem cells in red bone marrow stimulated by two major groups of regulatory glycoproteins:
    • Interleukins (ILs): Designated numerically (e.g., IL-1, IL-2).
    • Colony-Stimulating Factors (CSFs): Named according to the specific leukocytic lineage they induce.

  • Extravasation and Tissue Migration:

    • Diapedesis: Leukocytes leave the microcirculation by flattening and squeezing between adjacent vascular endothelial cells of postcapillary venules and capillaries.
    • Cellular Adhesion Molecules (CAMs): Endothelial and leukocytic surface selectins and integrins provide docking and traction, slowing leukocytes and guiding them through the vessel wall.
    • Ameboid Motion: Once situated in the interstitial fluid of connective tissues, leukocytes migrate via cytoplasmic projections.
    • Positive Chemotaxis: Injured, necrotic host cells and invading bacteria release inflammatory mediators that establish a chemical gradient, guiding leukocytes toward the infection focus.
    • Inflammation and Pus Formation:
    • Leukocyte secretions (e.g., histamine) stimulate local vasodilation and increased capillary permeability, causing fluid extravasation, erythema, and localized edema that limits pathogen dissemination.
    • As active phagocytosis proceeds, an accumulation of dead bacteria, necrotic host tissue fragments, and degenerating leukocytes collects as pus.

Leukocyte diapedesis through a capillary wall into connective tissue

  • Granulocytes:

    • Leukocytes possessing visible cytoplasmic granules when treated with Wright's stain. They feature lobed nuclei, develop in red bone marrow, average approximately twice the size of red blood cells, and have a short circulating lifespan (averaging about 12 hours12\,\text{hours}).

    • Neutrophils:

    • Morphology: Granules appear light purple to pink in a neutral mixture of acid and base stains. Mature cells exhibit complex nuclei divided into two to five segments connected by thin chromatin strands; termed polymorphonuclear leukocytes (PMNs) or "segs". Immature neutrophils possess C-shaped or curved nuclei and are termed "bands".

    • Abundance: Represent 50%–70%50\%\text{--}70\% of circulating leukocytes in adults.

    • Function: First responders to acute bacterial infection. Highly motile, aggressive phagocytes that destroy bacteria through a respiratory burst—generating a cytotoxic cloud of reactive oxygen species (including hydrogen peroxide and hypochlorite bleach). Their lysosomes contain hydrolases that digest phagocytized particles; neutrophils frequently die after engulfing large volumes of bacteria and toxins.

Micrograph of a mature neutrophil with a lobed nucleus

  • Eosinophils:
    • Morphology: Packed with coarse, uniform cytoplasmic granules that stain bright red to deep red with acidic dyes (eosin). Typically possess a bilobed nucleus.
    • Abundance: Represent 1%–3%1\%\text{--}3\% of circulating leukocytes.
    • Function: Weakly phagocytic toward bacteria. Specialize in secreting cytotoxic enzymes to kill macroscopic multicellular parasites, such as parasitic helminths (tapeworms, roundworms). They also phagocytize antigen-antibody complexes, helping downregulate inflammation and moderate allergic reactions.

Micrograph of an eosinophil displaying red cytoplasmic granules and adjacent platelets

  • Basophils:

    • Morphology: Contain irregularly sized, coarse cytoplasmic granules that stain deep blue to purple with basic stains (methylene blue). Granules are often numerous enough to obscure the bilobed nucleus.

    • Abundance: The rarest leukocyte class, accounting for less than 1%1\% of circulating white blood cells.

    • Function: Migrate to injured tissues to secrete heparin (an anticoagulant that inhibits intravascular clotting) and histamine (a vasoactive amine that increases vascular permeability and triggers local vasodilation to accelerate leukocyte recruitment). They are primary effectors in immediate hypersensitivity and allergic reactions.

    • Agranulocytes:

  • Leukocytes lacking prominent, distinctly staining specific cytoplasmic granules. Produced in red bone marrow, with certain lymphocyte populations migrating to the thymus for maturation.

  • Monocytes:

    • Morphology: The largest circulating formed elements, measuring two to three times the diameter of erythrocytes. Possess abundant cytoplasm with variable nuclear morphology (kidney-shaped, oval, indented, or lobed).
    • Abundance and Lifespan: Comprise 3%–9%3\%\text{--}9\% of circulating leukocytes; circulate for several days before entering tissues, where they survive for weeks or months.
    • Function: Leave the bloodstream to differentiate into highly active macrophages. Macrophages engulf large cellular debris, dead cells, and resistant microbes that overwhelm neutrophils. Contain numerous lysosomes with acid hydrolases.

Light micrograph of a large monocyte

  • Lymphocytes:
    • Morphology: The smallest leukocytes, only slightly larger than erythrocytes. Characterized by a large, dense, spherical nucleus surrounded by a thin peripheral rim of cytoplasm.
    • Abundance and Lifespan: Comprise 25%–33%25\%\text{--}33\% of circulating white blood cells; can survive for years.
    • Subtypes and Functions: Provide adaptive immunity:
    • T Lymphocytes (T Cells): Directly attack intracellular pathogens, tumor cells, and foreign allografts via cell-mediated cytotoxicity.
    • B Lymphocytes (B Cells): Differentiate into plasma cells that secrete soluble antibodies (immunoglobulins), which bind foreign antigens to flag them for destruction.

Leukocyte Counts, Diagnostic Differentials, and Hematologic Malignancies

  • Total and Differential Counts:

    • Normal White Blood Cell Count (WBCC/WCC): Ranges from 3,500–10,500 cells/μL3,500\text{--}10,500\,\text{cells}/\mu\text{L} of blood.
    • Diagnostic Preparation: Erythrocytes are chemically lysed before automated counting to prevent optical interference.
    • Leukocytosis: Elevation of total white blood cell count above 10,500 cells/μL10,500\,\text{cells}/\mu\text{L}. Indicates acute bacterial infection (e.g., appendicitis), physical trauma, vigorous exercise, severe dehydration, or emotional stress.
    • Leukopenia: Depletion of white blood cell count below 3,500 cells/μL3,500\,\text{cells}/\mu\text{L}. Associated with viral pathologies (influenza, measles, mumps, chickenpox, poliomyelitis, AIDS), typhoid fever, bone marrow hypoplasia, aplastic anemia, or heavy metal toxicity (arsenic, lead, mercury).
    • Differential White Blood Cell Count (DIFF): Quantifies relative percentages of each leukocyte type within a peripheral smear, helping identify specific disease states:
    • Elevated Neutrophils: Acute bacterial infections.
    • Elevated Eosinophils: Parasitic helminth infestations (tapeworms, hookworms), allergic reactions.
    • Elevated Monocytes: Chronic bacterial and intracellular infections (tuberculosis, typhoid fever, malaria).
    • Elevated Lymphocytes: Infectious mononucleosis, whooping cough, hairy cell leukemia.
    • Depleted Helper T Cells: Human immunodeficiency virus (HIV) infection and progressive AIDS.

  • Leukemia:

    • Pathophysiology: Malignant neoplasm of hematopoietic stem cell lines characterized by uncontrolled proliferation of abnormal, nonfunctional leukocytes flooding the marrow and blood.

Normal blood smear compared to peripheral blood smear in granulocytic leukemia

  • Lineage Classifications:
    • Myeloid (Myelogenous) Leukemia: Uncontrolled proliferation of myeloid stem cell derivatives (granulocytes and monocytes) in the red bone marrow.
    • Lymphoid (Lymphoblastic) Leukemia: Cancerous overproduction of lymphocyte precursors originating within bone marrow and secondary lymphoid organs (lymph nodes).
  • Clinical Classifications:
    • Acute Leukemia: Sudden onset, rapid progression, dominance of blast cells, and death within months without intervention.
    • Chronic Leukemia: Indolent progression, insidious onset; abnormal cells accumulate over years. Without treatment, survival averages roughly three years once symptoms appear.
  • Symptomatology: Arises directly from leukemic blast cells crowding out normal hematopoietic marrow lines:
    • Bone marrow crowding causes anemia, producing fatigue, pallor, and headache.
    • Megakaryocyte displacement causes thrombocytopenia, producing petechiae, ecchymoses, epistaxis, and prolonged clotting times.
    • Proliferating leukemic white blood cells are immunologically incompetent, causing frequent infections and persistent fevers.
    • Leukemic expansion within bone marrow cavities causes localized bone pain.
  • Therapeutic Innovations:
    • Targeted Kinase Inhibitors: Conventional chemotherapies broadly disrupt all rapidly dividing host cells. Targeted therapies selectively block ATP-binding sites on aberrant tyrosine kinase enzymes unique to malignant clones.
    • Molecular Profiling: Distinguishes classic acute lymphoblastic leukemia (ALL) from resistant variants like mixed-lineage leukemia, guiding targeted drug selection.
    • Stem Cell Therapies: Bone marrow or umbilical cord stem cell transplantation can reconstitute healthy hematopoiesis following marrow ablation.

Platelets (Thrombocytes) and Hemostatic Mechanisms

  • Genesis and Structural Properties:

    • Platelets are non-nucleated discoid cellular fragments measuring less than half the diameter of an erythrocyte.
    • Thrombopoiesis: Produced in red bone marrow from giant polyploid cells called megakaryocytes under the regulation of the hepatic/renal glycoprotein hormone thrombopoietin (TPO).
    • Fragment Shedding: Megakaryocytes extend long cytoplasmic projections through the sinusoidal endothelium of bone marrow vascular spaces. Shear stress from passing blood tears these extensions into circulating platelets.
    • Ultrastructure: Surrounded by a plasma membrane; packed with mitochondria, lysosomes, a dynamic cytoskeleton, and storage granules; capable of active ameboid motility.
    • Circulating Lifespan: Approximately 10 days10\,\text{days} before removal by reticuloendothelial macrophages.

  • Hemostatic and Secretory Roles:

    • Serotonin Release: Secreted by activated platelets to induce vascular smooth muscle contraction (vasospasm), reducing blood flow in injured vessels.
    • Thromboxane A2: Synthesized from arachidonic acid within platelet membrane phospholipids upon activation; acts as an autocrine/paracrine signal stimulating platelet shape change, degranulation, and aggregation.
    • Aspirin Pharmacology: Aspirin irreversibly inhibits the cyclooxygenase pathway required for thromboxane A2 synthesis, preventing platelet aggregation. Low-dose aspirin is used clinically to prevent arterial thrombosis.
    • Platelet-Derived Growth Factor (PDGF): Released from platelet alpha-granules to stimulate vascular repair by inducing local fibroblasts to synthesize collagen fibers and vascular smooth muscle cells to proliferate.
    • Clotting Dynamics: Platelet membranes display surface receptors that bind exposed subendothelial collagen, von Willebrand factor, and fibrinogen, organizing and stabilizing the mechanical thrombus.

  • Platelet Counts and Clinical Pathology:

    • Normal Count: 150,000–400,000 platelets/μL150,000\text{--}400,000\,\text{platelets}/\mu\text{L} of whole blood.
    • Thrombocytosis: Abnormal elevation of circulating platelets above 400,000/μL400,000/\mu\text{L}. Caused by reactive responses to systemic infection, chronic iron deficiency, or primary myeloproliferative disorders such as essential thrombocythemia (a genetic disorder causing megakaryocyte hyperplasia in patients over age 50). Increases the risk of both intravascular thrombosis and paradoxical bleeding.
    • Thrombocytopenia: Abnormally low circulating platelet count falling below 150,000/μL150,000/\mu\text{L}. Caused by marrow suppression from cytotoxic chemotherapy, ionizing radiation, aplastic anemia, acute leukemia, bone marrow transplantation, pregnancy, or autoimmune destruction. Manifests clinically as spontaneous capillary hemorrhages, prolonged bleeding, and pinpoint purple cutaneous petechiae. Treated via platelet transfusions and recombinant thrombopoietin (TPO).

Summary of Blood Formed Elements

  • Formed Element Reference Characteristics:
    • Erythrocytes (Red Blood Cells):
    • Morphology: Biconcave discs; lack nuclei and mitochondria; approximately one-third hemoglobin by volume.
    • Reference Count: Males 4,700,000–6,100,000/μL4,700,000\text{--}6,100,000/\mu\text{L}; Females 4,200,000–5,400,000/μL4,200,000\text{--}5,400,000/\mu\text{L}.
    • Function: Transports oxygen (O2\text{O}_2) and carbon dioxide (CO2\text{CO}_2).
    • Leukocytes (White Blood Cells):
    • Morphology: Complete nucleated cells; categorized into granulocytes and agranulocytes.
    • Reference Count: 3,500–10,500/μL3,500\text{--}10,500/\mu\text{L}.
    • Function: Protect against pathogenic microorganisms, eliminate neoplastic cells, and remove cellular debris.
    • Neutrophils (Granulocyte):
    • Morphology: Nucleus with two to five lobes; fine cytoplasmic granules staining light purple to pink.
    • Abundance: 50%–70%50\%\text{--}70\% of circulating leukocytes.
    • Function: Phagocytizes bacteria and small particles via respiratory burst.
    • Eosinophils (Granulocyte):
    • Morphology: Bilobed nucleus; coarse cytoplasmic granules staining deep red with acidic dyes.
    • Abundance: 1%–3%1\%\text{--}3\% of circulating leukocytes.
    • Function: Destroys macroscopic parasites; neutralizes inflammatory mediators in allergic reactions.
    • Basophils (Granulocyte):
    • Morphology: Bilobed nucleus obscured by large cytoplasmic granules staining deep blue with basic dyes.
    • Abundance: Less than 1%1\% of circulating leukocytes.
    • Function: Releases histamine (vasodilator) and heparin (anticoagulant) to coordinate inflammation.
    • Monocytes (Agranulocyte):
    • Morphology: Largest blood cell (two to three times red blood cell diameter); kidney-shaped or lobed nucleus; non-granular cytoplasm.
    • Abundance: 3%–9%3\%\text{--}9\% of circulating leukocytes.
    • Function: Leaves the circulation to become tissue macrophages that phagocytize large structures, microbes, and debris.
    • Lymphocytes (Agranulocyte):
    • Morphology: Slightly larger than an erythrocyte; large round nucleus filling nearly the entire cell with a narrow rim of cytoplasm.
    • Abundance: 25%–33%25\%\text{--}33\% of circulating leukocytes.
    • Function: Mediates adaptive immunity (T cells provide cellular cytotoxicity; B cells secrete humoral antibodies).
    • Platelets (Thrombocytes):
    • Morphology: Enucleated, discoid cytoplasmic fragments derived from megakaryocytes.
    • Reference Count: 150,000–400,000/μL150,000\text{--}400,000/\mu\text{L}.
    • Function: Mediates hemostasis, forms platelet plugs, releases vasoconstrictors, and promotes vascular repair.

Questions and Practice Review

  • Erythrocyte and Blood Cell Genesis:

    • Question: How do blood cells form?
    • Answer: Blood cells originate in the red bone marrow through the division and differentiation of hematopoietic stem cells (hemocytoblasts), a process termed hematopoiesis.
    • Question: Describe a red blood cell.
    • Answer: A red blood cell (erythrocyte) is an enucleated, biconcave disc measuring approximately 7.5 μm7.5\,\mu\text{m} across, thinner in its center than at its rim, lacking mitochondria and most organelles, and composed of roughly one-third hemoglobin by volume.
    • Question: How does the biconcave shape of a red blood cell make possible its function?
    • Answer: The biconcave geometry expands the total membrane surface area for gas diffusion while shortening the internal diffusion path to hemoglobin. It also provides flexibility, enabling the cell to bend and squeeze through microvascular capillary beds without rupturing.
    • Question: What is the function of hemoglobin?
    • Answer: Hemoglobin binds and transports oxygen from the lungs to systemic body tissues, and facilitates the return transport of a portion of carbon dioxide.
    • Question: What metabolic pathway do erythrocytes use to produce ATP?
    • Answer: Because mature erythrocytes lack mitochondria, they generate ATP entirely via anaerobic glycolysis.

  • Counts, Feedback Mechanisms, and Pathologies:

    • Question: What is the typical red blood cell count for an adult male? For an adult female?
    • Answer: The reference count for adult males is 4,700,000–6,100,000 cells/μL4,700,000\text{--}6,100,000\,\text{cells}/\mu\text{L}; for adult females, it is 4,200,000–5,400,000 cells/μL4,200,000\text{--}5,400,000\,\text{cells}/\mu\text{L}.
    • Question: Where are red blood cells produced?
    • Answer: In the embryo and fetus, erythrocytes are produced in the yolk sac, liver, and spleen. After birth, they are produced exclusively within red bone marrow.
    • Question: How does a red blood cell change as it matures?
    • Answer: A hematopoietic stem cell gives rise to an erythroblast, which divides and synthesizes hemoglobin. As it differentiates, its nucleus shrinks and is extruded along with a thin rim of membrane. The resulting reticulocyte exits the bone marrow, loses its residual organelle reticulum, and becomes a mature erythrocyte.
    • Question: How is red blood cell production controlled?
    • Answer: Erythropoiesis is regulated through a negative feedback loop mediated by erythropoietin (EPO). In response to hypoxemia, the kidneys (and liver) release EPO into the blood to stimulate bone marrow erythropoiesis. As the circulating red blood cell population restores oxygen delivery, EPO release declines.
    • Question: How might kidney disease affect red blood cell production and oxygen-carrying capacity?
    • Answer: Chronic kidney damage impairs erythropoietin secretion, blunting marrow stimulation, lowering total erythrocyte count, and reducing blood oxygen-carrying capacity.
    • Question: How might chronic lung disease result in polycythemia?
    • Answer: Chronic respiratory conditions like emphysema decrease the pulmonary surface area available for gas exchange. The resulting persistent arterial hypoxemia continuously drives the kidneys and liver to secrete EPO, stimulating bone marrow erythrocyte overproduction and resulting in secondary polycythemia.

  • Nutrition, Anemia, and Cell Senescence:

    • Question: Which vitamins are necessary for red blood cell production?
    • Answer: Vitamin B12 and folic acid are essential for DNA synthesis and normal cellular proliferation of hematopoietic stem cells in the red bone marrow.
    • Question: Why is iron required for the formation of red blood cells?
    • Answer: Iron is an essential structural element of the heme group within hemoglobin, which is required to bind oxygen.
    • Question: What is anemia?
    • Answer: Anemia is a clinical condition characterized by an abnormal reduction in the circulating red blood cell count or a deficiency in the quantity of hemoglobin per erythrocyte, reducing tissue oxygenation.
    • Question: What happens to damaged red blood cells?
    • Answer: Aging and mechanically damaged erythrocytes rupture within the narrow capillary networks of the spleen and liver, where tissue macrophages phagocytize and decompose their cellular components.
    • Question: What are the products of hemoglobin breakdown?
    • Answer: Hemoglobin breakdown produces free amino acids (from digested globin chains), iron, biliverdin, and bilirubin.

  • Leukocyte Biology and Kinetics:

    • Question: Which hormones are necessary for the differentiation of white blood cells from hematopoietic stem cells in red bone marrow?
    • Answer: Interleukins and colony-stimulating factors (CSFs) drive leukocyte differentiation.
    • Question: How do white blood cells reach microorganisms outside blood vessels?
    • Answer: Leukocytes squeeze through postcapillary endothelial cell junctions via diapedesis, guided by cellular adhesion molecules, and navigate tissue spaces using ameboid locomotion.
    • Question: What is positive chemotaxis?
    • Answer: Positive chemotaxis is the directional migration of leukocytes toward areas of inflammation, guided by chemical signals released by damaged cells and bacteria.
    • Question: Distinguish between granulocytes and agranulocytes.
    • Answer: Granulocytes (neutrophils, eosinophils, basophils) have prominent, specifically staining cytoplasmic granules and lobed nuclei. Agranulocytes (monocytes, lymphocytes) lack conspicuous specific cytoplasmic granules.
    • Question: List five types of white blood cells, and explain how they differ from one another in form and function.
    • Answer:
      1. Neutrophils: Multilobed (2 to 5 lobes) nuclei with fine pink/purple granules; active early phagocytes that destroy bacteria via respiratory burst.
      2. Eosinophils: Bilobed nuclei with coarse red granules; kill parasitic worms and modulate allergic inflammation.
      3. Basophils: Bilobed nuclei masked by coarse blue granules; secrete heparin (anticoagulant) and histamine (vasodilator).
      4. Monocytes: Large agranulocytes with variable kidney-shaped or oval nuclei; enter tissues to become macrophages that engulf large debris and pathogens.
      5. Lymphocytes: Small cells with large spherical nuclei and minimal cytoplasm; coordinate adaptive immunity (T cells direct cytotoxicity; B cells secrete antibodies).
    • Question: Which white blood cells are the most active phagocytes?
    • Answer: Neutrophils and monocytes (macrophages) are the most active phagocytic cells.
    • Question: What is the normal human white blood cell count?
    • Answer: The reference range is 3,500–10,500 cells/μL3,500\text{--}10,500\,\text{cells}/\mu\text{L} of whole blood.
    • Question: Distinguish between leukocytosis and leukopenia.
    • Answer: Leukocytosis is an elevation of total white blood cell count above 10,500/μL10,500/\mu\text{L}, whereas leukopenia is a depression of white blood cell count below 3,500/μL3,500/\mu\text{L}.
    • Question: What is a differential white blood cell count?
    • Answer: A differential count calculates the relative percentages of each leukocyte type within a stained blood smear to help identify specific infectious, inflammatory, or neoplastic conditions.
    • Question: Which cells would be seen as abnormal and excessive in number in the blood of a patient who has a cancer known as myeloid (myelogenous) leukemia?
    • Answer: Immature and abnormal granulocytes (neutrophils, eosinophils, basophils) and monocytes.

  • Platelet Biology:

    • Question: What are some functions of blood platelets?
    • Answer: Platelets aggregate to plug vascular defects, release serotonin to trigger localized vasoconstriction, secrete platelet-derived growth factor to stimulate tissue repair, release thromboxane A2 to recruit additional platelets, and provide a catalytic surface for coagulation cascades.
    • Question: What is the normal human blood platelet count?
    • Answer: The normal human blood platelet count ranges from 150,000–400,000 platelets/μL150,000\text{--}400,000\,\text{platelets}/\mu\text{L} of blood.